New evidence suggests that the antiviral drug molnupiravir, used to treat patients with COVID-19, appears to be causing SARS-CoV-2 to mutate and evolve, and that some...
Using cutting-edge model systems, researchers at Weill Cornell Medicine have uncovered a mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes...
The evidence is piling up, Efficacy The U.S. Food and Drug Administration (FDA) is considering approving psilocybin, the active ingredient in “magic mushrooms,” as a treatment...
Genomic regions associated with Alzheimer's disease and dementia in African populations will be presented at the “Future of Dementia in Africa” ​​conference, taking place September 11-12,...
In a world still struggling with the aftermath of the COVID-19 pandemic, an international team of researchers has proposed a new approach to treat the persistent...
In a recently published study, Nature Biomedical EngineeringA group of researchers optimized prime editing (PE) to efficiently correct the cystic fibrosis (CF) transmembrane conductance regulator (CFTR)...
Recent Comments